• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Return on Investment: 2010 grant winners discuss their research spending

by Richard Quinn • September 2, 2011

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

After successfully showing slowed tumor growth in mice, Dr. Kim is now working to show how toll-like receptor (TLR) agonists can be used as tumor cell vaccine adjuvants. His research has taught him that simply combining the agonists and the vaccine isn’t enough. He and his team have worked on formulating the biologic engineering required to get the vaccine to absorb the adjuvants. Also, because the formula is not as simple as one agonist for one vaccine, Dr. Kim and his colleagues are working on seemingly countless possibilities for different agonist combinations.

You Might Also Like

  • COSM 2012: TRIO Poster Winners Discuss their Projects
  • How to Land an NIH Grant
  • A Boost for Research: The Triological Society’s grants help physician-scientists launch investigative careers
  • Research Overhaul: Changes to cancer research organizations on the horizon, expert says
Explore This Issue
September 2011

Although all his tests have been on animals to date, Dr. Kim said he is about a year away from beginning patient tests. Specifically, he is looking to pair his science with a colleague’s GVAX for melanoma. Of course, he has his eye on similar vaccines for other cancers, including squamous cell carcinoma, but the holders of some vaccines are companies, and the approval process to formalize those partnerships can take time.

And Dr. Kim is eager to get to work.

“What are the key adjuvants that are important to make tumor vaccines, cancer vaccines work?” he said. “We have decades of experience with multiple labs trying to target tumor antigens, and they clearly have not worked by themselves.”

Michael E. Kupferman, MD

Michael E. Kupferman, MD, Assistant Professor, Department of Head and Neck Surgery, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston

Dr. Kupferman was the only Clinical Scientist Development Award winner from 2010 in the first year of the grant. His research is focused on how neurotrophin receptors impact the progression of head and neck cancers, particularly oral cancers. He originally received an NIH grant in 2009 that will provide more than $525,000 over five years. His new grant is $80,000 per year for four years.

“We currently use a ‘one size fits all’ approach to treating these cancers … gleaning insights from how these tumors are behaving based on a particular molecular profile may give us insight in how to individualize treatment,” Dr. Kupferman said.

Dr. Kupferman is now hopeful his current funding is just a first step toward a larger proposal he’s drafting. His team has begun looking not just at tumor cells, but also at the surrounding support cells, which he dubs “the neighborhood within which the tumor lives.” He is hopeful a future NIH grant will fund deeper research down that path.

Pages: 1 2 3 4 5 6 7 8 | Single Page

Filed Under: Career Development, Head and Neck, Medical Education Tagged With: National Institutes of Health (NIH), research, Triological SocietyIssue: September 2011

You Might Also Like:

  • COSM 2012: TRIO Poster Winners Discuss their Projects
  • How to Land an NIH Grant
  • A Boost for Research: The Triological Society’s grants help physician-scientists launch investigative careers
  • Research Overhaul: Changes to cancer research organizations on the horizon, expert says

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • Otolaryngologists as Entrepreneurs: Transforming Patient Care And Practice

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Physician Handwriting: A Potentially Powerful Healing Tool

    • Continued Discussion And Engagement Are Essential To How Otolaryngologists Are Championing DEI Initiatives In Medicine

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Physician Handwriting: A Potentially Powerful Healing Tool
    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939